Delivery Order SPE2DB22D3011-SPE2DB25FP9WH
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,737.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a critical medical product, with a completion date of January 28, 2025. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,142.59 for the supply of RABAVERT Rabies Vaccine with diluents. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 15, 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This federal contract award is a delivery order valued at $2,613.14 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, with a period of performance through May 31, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of RABAVERT RABIES VACC W-DILUENTS to the Defense Logistics Agency (DLA). The $9,178.15 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 3, 2023, with a completion date of March 6, 2023. The contract is not designated with any set-aside requirements. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,431.10 firm fixed-price delivery order is for RABAVERT RABIES VACC W-DILUENTS, a critical medical commodity. The contract has an ultimate completion date of February 28, 2025 and was awarded on February 27, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RABAVERT RABIES VACC W-DILUENTS to the Defense Logistics Agency (DLA). The $2,045.08 firm fixed-price delivery order has a completion date of December 12, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,161.90 firm fixed-price delivery order is for the procurement of RABAVERT rabies vaccine with diluents, with a performance period through March 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,191.60 Firm Fixed Price Delivery Order is for the procurement of RABAVERT RABIES VACC W-DILUENTS, with a period of performance through March 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $8,945.46 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of RABAVERT RABIES VACC W-DILUENTS and has an ultimate completion date of May 10, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp as the prime contractor. The firm-fixed-price delivery order has a ceiling value of $3,860.60 and a completion date of November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...